Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Mini Reviews in Medicinal Chemistry
|
December 1, 2017
Assorted Applications of N-substituted-2,4-thiazolidinediones in Various Pathological Conditions
Rakesh Gupta, Hardik Joshi, C S Ramaa
Expert Opinion on Investigational Drugs
|
March 7, 2014
A new dawn for the use of thiazolidinediones in cancer therapy
Hardik Joshi, Tanushree Pal, C S Ramaa
Anti-Cancer Agents in Medicinal Chemistry
|
May 31, 2014
Design and development of oxazol-5-ones as potential partial PPAR-γ agonist against cancer cell lines
Tanushree Pal, Hardik Joshi, C S Ramaa
Anti-Cancer Agents in Medicinal Chemistry
|
April 24, 2018
Novel Anthraquinone Derivatives as Dual Inhibitors of Topoisomerase 2 and Casein Kinase 2: In Silico Studies, Synthesis and Biological Evaluation on Leukemic Cell Lines
Abbas Kabir, Kalpana Tilekar, Neha Upadhyay, et al.
Bioorganic & Medicinal Chemistry
|
February 20, 2013
Thiazolidine-2,4-diones: progress towards multifarious applications
Viral S Jain, Dhagash K Vora, C S Ramaa
Anti-Cancer Agents in Medicinal Chemistry
|
June 14, 2016
Hydroxy Cinnamic Acid Derivatives as Partial PPARγ Agonists: In silico Studies, Synthesis and Biological Characterization Against Chronic Myeloid Leukemia Cell Line (K562)
Hardik Joshi, Kavita Marulkar, Vikram Gota, et al.
Bioorganic Chemistry
|
June 20, 2025
Peroxisome proliferator-activated receptor antagonists as emerging therapeutics in cancer treatment
Snehal Misal, Vijay M Patil, C S Ramaa, et al.
Iranian Journal of Pharmaceutical Research : IJPR
|
March 19, 2020
Development of 1,2,4-Triazole-5-Thione Derivatives as Potential Inhibitors of Enoyl Acyl Carrier Protein Reductase (InhA) in Tuberculosis
Dhagash Vora, Neha Upadhyay, Kalpana Tilekar, et al.
Iranian Journal of Pharmaceutical Research : IJPR
|
February 23, 2022
Hypoglycemic and Hypolipidemic Swords: Synthesis and <i>In-vivo</i> Biological Assessment of 5-benzylidene-2,4-thiazolidinediones
Vijay Patil, Neha Upadhyay, Kalpana Tilekar, et al.
Current Pharmaceutical Biotechnology
|
February 14, 2006
Nutraceuticals--an emerging era in the treatment and prevention of cardiovascular diseases
C S Ramaa, A R Shirode, A S Mundada, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Mini Reviews in Medicinal Chemistry
|
December 1, 2017
Assorted Applications of N-substituted-2,4-thiazolidinediones in Various Pathological Conditions
Rakesh Gupta, Hardik Joshi, C S Ramaa
Expert Opinion on Investigational Drugs
|
March 7, 2014
A new dawn for the use of thiazolidinediones in cancer therapy
Hardik Joshi, Tanushree Pal, C S Ramaa
Anti-Cancer Agents in Medicinal Chemistry
|
May 31, 2014
Design and development of oxazol-5-ones as potential partial PPAR-γ agonist against cancer cell lines
Tanushree Pal, Hardik Joshi, C S Ramaa
Anti-Cancer Agents in Medicinal Chemistry
|
April 24, 2018
Novel Anthraquinone Derivatives as Dual Inhibitors of Topoisomerase 2 and Casein Kinase 2: In Silico Studies, Synthesis and Biological Evaluation on Leukemic Cell Lines
Abbas Kabir, Kalpana Tilekar, Neha Upadhyay, et al.
Bioorganic & Medicinal Chemistry
|
February 20, 2013
Thiazolidine-2,4-diones: progress towards multifarious applications
Viral S Jain, Dhagash K Vora, C S Ramaa
Anti-Cancer Agents in Medicinal Chemistry
|
June 14, 2016
Hydroxy Cinnamic Acid Derivatives as Partial PPARγ Agonists: In silico Studies, Synthesis and Biological Characterization Against Chronic Myeloid Leukemia Cell Line (K562)
Hardik Joshi, Kavita Marulkar, Vikram Gota, et al.
Bioorganic Chemistry
|
June 20, 2025
Peroxisome proliferator-activated receptor antagonists as emerging therapeutics in cancer treatment
Snehal Misal, Vijay M Patil, C S Ramaa, et al.
Iranian Journal of Pharmaceutical Research : IJPR
|
March 19, 2020
Development of 1,2,4-Triazole-5-Thione Derivatives as Potential Inhibitors of Enoyl Acyl Carrier Protein Reductase (InhA) in Tuberculosis
Dhagash Vora, Neha Upadhyay, Kalpana Tilekar, et al.
Iranian Journal of Pharmaceutical Research : IJPR
|
February 23, 2022
Hypoglycemic and Hypolipidemic Swords: Synthesis and <i>In-vivo</i> Biological Assessment of 5-benzylidene-2,4-thiazolidinediones
Vijay Patil, Neha Upadhyay, Kalpana Tilekar, et al.
Current Pharmaceutical Biotechnology
|
February 14, 2006
Nutraceuticals--an emerging era in the treatment and prevention of cardiovascular diseases
C S Ramaa, A R Shirode, A S Mundada, et al.
Page
of 3